The McGill University Health Centre is one of two major healthcare networks in the city of Montreal, Quebec. It is affiliated with McGill University and is one of the largest medical institutions in Canada. It is the largest hospital system in Canada by bed capacity.

There are 1,379 beds in Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC.

During the past decade, Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC" are "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC" in a lesser frequency.

Most popular intervention types in "Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials), "Placebo" (1 trials) and "Placebo SC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".